科研动态PubMed 摘要

移动应用程序对孕期母亲体重相关结局及新生儿出生体重结局的影响:一项系统评价与荟萃分析。

PubMed 学科轮询 · 2026-08-13

完整摘要 · 中文译文

背景:妊娠期体重增长超出推荐范围与不良母儿结局相关。鉴于移动应用程序的广泛使用,其可能支持妊娠期体重管理。 目的:评估移动应用程序对妊娠期母亲体重相关结局及新生儿出生体重相关结局的效果。 方法:我们开展了一项关于评估移动应用程序用于妊娠期体重管理的随机对照试验的系统综述与荟萃分析,检索更新至2026年7月。可比较的结局采用固定效应模型和随机效应模型进行合并,优先采用随机效应模型估计值。 结果:共纳入12项研究,涉及3778名孕妇。移动应用程序降低妊娠期体重(MD -0.67 kg;CI95% -1至0)和出生体重(MD -32 g;CI95% -140至75)。然而,观察到一种矛盾趋势,即移动应用程序似乎降低母亲体重过度的风险(RR 0.81;CI95% 0.66-1.00),同时却增加母亲体重不足的风险(RR 1.02;CI95% 0.67-1.54)。这一趋势也反映在新生儿结局中,因为大于胎龄儿(RR 0.73;CI95% 0.54-1.00)和体重>4000 g(RR 0.90;CI95% 0.74-1.09)的风险似乎降低,而小于胎龄儿(RR 1.22;CI95% 0.93-1.59)和出生体重<2500 g(RR 1.41;CI95% 0.93-2.14)的风险增加。 结论:关于移动应用程序用于妊娠期体重管理的证据仍具有异质性,提示可能存在获益和危害。更精确的证 需要证据来阐明临床相关性及其对临床实践的意义。 临床试验编号:PROSPERO CRD42023458719。

完整摘要 · 英文原文

BACKGROUND: Gestational weight gain outside recommended ranges is associated with adverse maternal and neonatal outcomes. Given their widespread use, mobile apps may support weight management during pregnancy. AIM: To evaluate the efficacy of mobile apps on maternal weight-related outcomes during pregnancy and neonatal birth weight-related outcomes. METHODS: We conducted a systematic review and meta-analysis of randomized controlled trials evaluating mobile apps for weight management during pregnancy, with searches updated through July 2026. Comparable outcomes were pooled using fixed-effect and random-effects models, with random-effects estimates prioritized. RESULTS: Twelve studies involving 3778 pregnant women were included. Mobile apps decrease the gestational weight (MD -0.67 kg; CI95% -1 to 0) and birth weight (MD -32 g; CI95% -140 to 75). However, a paradoxical trend was observed in which mobile apps appeared to reduce the risk of excessive maternal weight (RR 0.81; CI95% 0.66-1.00), while at the same time increased risk of inadequate maternal weight (RR 1.02; CI95% 0.67-1.54). This trend was also reflected in neonatal outcomes, as the risk of newborns being large for gestational age (RR 0.73; CI95% 0.54-1.00) and weight > 4000 g (RR 0.90; CI95% 0.74-1.09) appeared to decrease, whereas the risk of being small for gestational age (RR 1.22; CI95% 0.93-1.59) and birth weight < 2500 g (RR 1.41; CI95% 0.93-2.14) increased. CONCLUSIONS: Evidence on mobile apps for gestational weight management remains heterogeneous, suggesting potential benefits and harms. More precise evidence is needed to clarify clinical relevance and their implications for clinical practice. CLINICAL TRIAL NUMBER: PROSPERO CRD42023458719.

English
Effects of mobile apps on maternal weight-related and neonatal birth weight outcomes during pregnancy: a systematic review and meta-analysis.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界